Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 271 AL 285

Brain Metabolic Alterations in Alzheimer's Disease

Ardanaz CG, Ramírez MJ, Solas M.

Int J Mol Sci. 2022 Mar 29;23(7):3785. doi: 10.3390/ijms23073785.

Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90

Heath L, Earls JC, Magis AT, Kornilov SA, Lovejoy JC, Funk CC, Rappaport N, Logsdon BA, Mangravite LM, Kunkle BW, Martin ER, Naj AC, Ertekin-Taner N, Golde TE, Hood L, Price ND; Alzheimer’s Disease Genetics Consortium.

Sci Rep. 2022 Apr 12;12(1):6117. doi: 10.1038/s41598-022-09825-2.

Altered peripheral factors affecting the absorption, distribution, metabolism, and excretion of oral medicines in Alzheimer's disease

Waller ES, Yardeny BJ, Fong WY, Gan XY, Jimenez SV, Pan Y, Abasszade JH, Nicolazzo JA.

Adv Drug Deliv Rev. 2022 Jun;185:114282. doi: 10.1016/j.addr.2022.114282. Epub 2022 Apr 11.

Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications

Uddin MS, Lim LW.

Ageing Res Rev. 2022 Jun;78:101622. doi: 10.1016/j.arr.2022.101622. Epub 2022 Apr 12.

The Effect of Gut Microbe Dysbiosis on the Pathogenesis of Alzheimer's Disease (AD) and Related Conditions

Nafady MH, Sayed ZS, Abdelkawy DA, Shebl ME, Elsayed RA, Ashraf GM, Perveen A, Attia MS, Bahbah EI.

Curr Alzheimer Res. 2022;19(4):274-284. doi: 10.2174/1567205019666220419101205.

Glucose metabolism and AD: evidence for a potential diabetes type 3

González A, Calfío C, Churruca M, Maccioni RB.

Alzheimers Res Ther. 2022 Apr 20;14(1):56. doi: 10.1186/s13195-022-00996-8.

The synapse as a treatment avenue for Alzheimer's Disease

Peng L, Bestard-Lorigados I, Song W.

Mol Psychiatry. 2022 Jul;27(7):2940-2949. doi: 10.1038/s41380-022-01565-z. Epub 2022 Apr 20.

Alzheimer's Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore

Botelho MJ, Milinovic J, Bandarra NM, Vale C.

Mar Drugs. 2022 Apr 2;20(4):253. doi: 10.3390/md20040253.

Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer's Disease

Islam F, Khadija JF, Harun-Or-Rashid M, Rahaman MS, Nafady MH, Islam MR, Akter A, Emran TB, Wilairatana P, Mubarak MS.

Oxid Med Cell Longev. 2022 Apr 11;2022:5100904. doi: 10.1155/2022/5100904. eCollection 2022.

GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update

Chauhan N, Paliwal S, Jain S, Verma K, Paliwal S, Sharma S.

Mini Rev Med Chem. 2022;22(22):2881-2895. doi: 10.2174/1389557522666220420094317.

The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials

Tseng PT, Zeng BY, Chen YW, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, Lin PY, Carvalho AF, Stubbs B, Matsuoka YJ, Li DJ, Liang CS, Hsu CW, Sun CK, Cheng YS, Yeh PY, Shiue YL.

Curr Neuropharmacol. 2022;20(10):1816-1833. doi: 10.2174/1570159X20666220420122322.

Histone deacetylase-6 modulates Tau function in Alzheimer's disease

Qureshi T, Chinnathambi S.

Biochim Biophys Acta Mol Cell Res. 2022 Aug;1869(8):119275. doi: 10.1016/j.bbamcr.2022.119275. Epub 2022 Apr 20.

ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease

Li Y, Macyczko JR, Liu CC, Bu G.

Neurobiol Aging. 2022 Jul;115:20-28. doi: 10.1016/j.neurobiolaging.2022.03.011. Epub 2022 Mar 22.

Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs

Fagone P, Mangano K, Martino G, Quattropani MC, Pennisi M, Bella R, Fisicaro F, Nicoletti F, Petralia MC.

Genes (Basel). 2022 Apr 15;13(4):703. doi: 10.3390/genes13040703.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias